Diamanti-Kandarakis E - Search Results

1

MECHANISMS IN ENDOCRINOLOGY: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women.

Diamanti-Kandarakis E, Papalou O, Kandaraki EA, Kassi G. Diamanti-Kandarakis E, et al. Eur J Endocrinol. 2017 Feb;176(2):R79-R99. doi: 10.1530/EJE-16-0616. Epub 2016 Sep 27. Eur J Endocrinol. 2017. PMID: 27678478 Review.

2

Oxidative Stress in Polycystic Ovary Syndrome.

Papalou O, Victor VM, Diamanti-Kandarakis E. Papalou O, et al. Curr Pharm Des. 2016;22(18):2709-22. doi: 10.2174/1381612822666160216151852. Curr Pharm Des. 2016. PMID: 26881435 Review.

3

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.

Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Diamanti-Kandarakis E, et al. Eur J Endocrinol. 2010 Feb;162(2):193-212. doi: 10.1530/EJE-09-0733. Epub 2009 Oct 19. Eur J Endocrinol. 2010. PMID: 19841045 Review.

4

Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats.

Chatzigeorgiou A, Kandaraki E, Piperi C, Livadas S, Papavassiliou AG, Koutsilieris M, Papalois A, Diamanti-Kandarakis E. Chatzigeorgiou A, et al. J Endocrinol. 2013 Aug 29;218(3):331-7. doi: 10.1530/JOE-13-0175. Print 2013 Sep. J Endocrinol. 2013. PMID: 23823020

5

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

Androulakis II, Kandaraki E, Christakou C, Karachalios A, Marinakis E, Paterakis T, Diamanti-Kandarakis E. Androulakis II, et al. Clin Endocrinol (Oxf). 2014 Sep;81(3):426-31. doi: 10.1111/cen.12447. Epub 2014 Apr 15. Clin Endocrinol (Oxf). 2014. PMID: 24601936

6

Postprandial dysmetabolism: Too early or too late?

Pappas C, Kandaraki EA, Tsirona S, Kountouras D, Kassi G, Diamanti-Kandarakis E. Pappas C, et al. Hormones (Athens). 2016 Jul;15(3):321-344. doi: 10.14310/horm.2002.1697. Hormones (Athens). 2016. PMID: 27838603 Free article. Review.

7

Is cardiovascular risk in women with PCOS a real risk? Current insights.

Papadakis G, Kandaraki E, Papalou O, Vryonidou A, Diamanti-Kandarakis E. Papadakis G, et al. Minerva Endocrinol. 2017 Dec;42(4):340-355. doi: 10.23736/S0391-1977.17.02609-8. Epub 2017 Jan 31. Minerva Endocrinol. 2017. PMID: 28146139 Review.

8

The role of stress in PCOS.

Papalou O, Diamanti-Kandarakis E. Papalou O, et al. Expert Rev Endocrinol Metab. 2017 Jan;12(1):87-95. doi: 10.1080/17446651.2017.1266250. Epub 2016 Dec 7. Expert Rev Endocrinol Metab. 2017. PMID: 30058880

9

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease.

Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Papalou O, et al. Front Endocrinol (Lausanne). 2019 Mar 1;10:112. doi: 10.3389/fendo.2019.00112. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30881345 Free PMC article. Review.

10

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review.

Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O, Diamanti-Kandarakis E. Papadakis G, et al. Among authors: diamanti kandarakis e. Front Endocrinol (Lausanne). 2019 Jun 19;10:388. doi: 10.3389/fendo.2019.00388. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31275245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters